Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
| ABAGS | ASP-USSMALL-SSF | |
|---|---|---|
| Only in ABAGS | ||
| Ligand Pharmaceuticals | 2.90% | N/A |
| Q2 | 2.82% | N/A |
 Kiniksa Pharmaceuticals Inte… | 2.78% | N/A |
 Magnolia Oil & Gas Corporati… | 2.78% | N/A |
| Only in ASP-USSMALL-SSF | ||
 Guardant Health | N/A | 2.34% |
 Praxis Precision | N/A | 2.04% |
 Spyre Therapeutics | N/A | 1.94% |
 JFrog | N/A | 1.73% |
30 Dec 2025 → 2 Nov 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| ABAGS | +7.86% | 16.88% | 0.47 |
| ASP-USSMALL-SSF | −10.74% | 23.74% | −0.45 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | ABAGS | ASP-USSMALL-SSF |
|---|---|---|
Fund details | ||
| Fund size | 297 million | 0.62 million |
| Inception date | 3 Nov 2015 | 29 Nov 2023 |
| Master fund | abrdn SICAV I - North American Smaller Companies Fund | Driehaus US Small Cap Equity Fund |
| Dividend policy | Does not pay | Does not pay |
Risk and currency hedging | ||
| Risk level | 6 | 6 |
| Hedging policy | Hedged at the manager's discretion | Almost fully hedged |
| Share hedged | 100.94% | 100.79% |
Minimum purchase and redemption | ||
| First purchase | 1,000 THB | 1,000 THB |
| Subsequent purchase | 1,000 THB | 1,000 THB |
| Redemption (amount) | 1,000 THB | No minimum |
| Redemption (units) | 100 units | No minimum |
| Balance (amount) | No minimum | No minimum |
| Balance (units) | 100 units | No minimum |
Order cut-off and redemption payment | ||
| Buy before | 15:30 | 15:30 |
| Redeem before | 13:00 | 15:30 |
| Redemption paid | T+5 | T+4 |
